ReCAP2027 is designed for professionals involved in the development, regulatory approval, quality management and commercialisation of pharmaceutical and medical device combination products.
Pharmaceutical and Biopharmaceutical Companies
Professionals working in regulatory affairs, research and development, product development, manufacturing and drug delivery.
Medical Device Manufacturers
Companies developing medical devices, drug delivery systems and technologies intended to be combined with medicinal products.
Regulatory Affairs Professionals
Specialists responsible for regulatory strategy, EU MDR compliance, marketing authorisation, regulatory submissions and product classification.
Quality Assurance and Compliance Teams
Professionals managing quality systems, risk management, product safety, documentation and regulatory compliance throughout the product lifecycle.
Combination Product Developers
Teams developing pre-filled syringes, auto-injectors, inhalers, wearable injectors and other drug-device delivery systems.
CDMOs and Industry Service Providers
Contract development and manufacturing organisations, testing laboratories and technical service providers supporting combination product development and manufacturing.
Regulatory Consultants and Experts
Independent consultants and specialist advisers supporting companies with regulatory, quality, clinical and technical requirements.
Start-ups and SMEs
Contract development and manufacturing organisations, testing laboratories and technical service providers supporting combination product development and manufacturing.
